The COVID-19 Pandemic Is Associated with Reduced Survival after Pancreatic Ductal Adenocarcinoma Diagnosis: A Single-Centre Retrospective Analysis

The COVID-19 pandemic has hugely disrupted healthcare provision, including oncology services. To evaluate the effects of the pandemic on referral routes leading to diagnosis, treatments, and prognosis in patients with pancreatic ductal adenocarcinoma, we performed a retrospective cohort study at a s...

Descripción completa

Detalles Bibliográficos
Autores principales: Madge, Oliver, Brodey, Alexandra, Bowen, Jordan, Nicholson, George, Sivakumar, Shivan, Bottomley, Matthew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105306/
https://www.ncbi.nlm.nih.gov/pubmed/35566700
http://dx.doi.org/10.3390/jcm11092574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105306/
https://www.ncbi.nlm.nih.gov/pubmed/35566700
http://dx.doi.org/10.3390/jcm11092574

Ejemplares similares